Percutaneous Cryoablation of Symptomatic Extraabdominal Metastatic Disease: Preliminary Results

Overview

Journal AJR Am J Roentgenol

Specialties Oncology
Radiology

Date 2005 Feb 25

PMID 15728619

Citations 9

Authors

Michael D Beland

Damian E Dupuy

William W Mayo-Smith

Affiliations

Soon will be listed here.

Abstract

Objective: The objective of our study was to describe our initial experience using percutaneous cryoablation for palliation of symptomatic extraabdominal metastases or recurrent soft-tissue tumors.

Conclusion: Preliminary results suggest that percutaneous cryoablation may offer a minimally invasive alternative for relief of symptomatic metastatic disease in patients for whom conventional therapy failed.

Citing Articles

Preliminary experience in the management of brain and skull-base tumors with microwave ablation; feasibility guided by ultrasound, report from 23 cases.

Ramirez A, Rodriguez P, Gutierrez S, Avila O Surg Neurol Int. 2019; 10:17.

PMID: 31123624 PMC: 6416755. DOI: 10.4103/sni.sni_361_18.

Cryoablation combined with zoledronic acid in comparison with cryoablation and zoledronic acid alone in the treatment of painful bone metastases.

Li F, Wang W, Li L, Su D, Chang Y, Guo G Exp Ther Med. 2014; 8(2):539-544.

PMID: 25009616 PMC: 4079393. DOI: 10.3892/etm.2014.1784.

Percutaneous treatment of a sacral metastasis with combined embolization, cryoablation, alcohol ablation and sacroplasty for local tumor and pain control.

Lee J, Stein M, Roychowdhury S Interv Neuroradiol. 2013; 19(2):250-3.

PMID: 23693052 PMC: 3670067. DOI: 10.1177/159101991301900217.

Percutaneous bone tumor management.

Gangi A, Buy X Semin Intervent Radiol. 2011; 27(2):124-36.

PMID: 21629402 PMC: 3036514. DOI: 10.1055/s-0030-1253511.

A simple technique for interventional tool placement combining fluoroscopy with interventional computed tomography on a C-arm system.

Nett B, Aagaard-Kienitz B, Serarslan Y, Baskaya M, Chen G Neurosurgery. 2010; 67(3 Suppl Operative):ons49-56.

PMID: 20679948 PMC: 6758548. DOI: 10.1227/01.NEU.0000382976.18891.50.